JANE HICKNEY: Open Payments
NPI 1144393752 · TORRANCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,547 in 62 payments from 16 companies in 2025. Trend: 2023 $952 · 2024 $1,810 · 2025 $1,547
Food & beverage: $1,495Education: $52
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $240 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $201 |
| Ardelyx, Inc. | 8 | $199 |
| Amgen Inc. | 6 | $168 |
| Otsuka America Pharmaceutical, Inc. | 7 | $144 |
| Aurinia Pharma U.S., Inc. | 5 | $114 |
| AstraZeneca Pharmaceuticals LP | 5 | $111 |
| AKEBIA THERAPEUTICS INC | 3 | $78 |
| Calliditas Therapeutics US Inc. | 2 | $58 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $52 |
Products named: Kerendia, JARDIANCE, IBSRELA, JYNARQUE, KRYSTEXXA, LUPKYNIS, FARXIGA, VOYXACT.
Industry payments across CA — which companies pay providers there.
